Jiangxi Tianxin Pharmaceutical Co., Ltd.

Jiangxi Tianxin Pharmaceutical Co., Ltd. was founded in September 2004 and is recognized as a national high-tech enterprise focused on the production, R&D, and sales of individual vitamin products. After nearly two decades of steady growth, it has become a key global supplier in the vitamin market. On July 12, 2022, the company was successfully listed on the main board of the Shanghai Stock Exchange (stock name: Tianxin Pharmaceutical; stock code: 603235). The company delivers comprehensive solutions for global clients in sectors such as human health and animal nutrition. Its product portfolio includes Vitamin B6, Vitamin B1, folic acid, Vitamin D3, biotin, ascorbyl palmitate, calcium pantothenate, Vitamin A acetate, Vitamin E powder, ABL, L-alanine, sodium methoxide, and more. These products are primarily used as raw materials, food additives, and feed additives. Tianxin holds significant global market shares in various vitamin categories, with Vitamin B6 and B1 leading internationally, and folic acid and biotin ranking among the top in the industry. Guided by the principle of “Day by Day, Step by Step,” the company has consistently pursued product innovation and specialization. It has established a dedicated R&D center in Shanghai and the Jiangxi Vitamin Engineering Technology Research Center. Furthermore, it actively contributes to the development of national standards for vitamin B6 feed additives and thiamine nitrate used in food.